Article

Safety and Efficacy of TKIs in Very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia

2023-12-08

Abstract excerpt

<h4>Background: </h4> While outcomes of chronic phase chronic myeloid leukemia (CP-CML) patients aged over 65 years have been extensively evaluated in real-life experiences, limited data exist for the very elderly population (i.e., aged ≥ 75 years), especially for next-generation tyrosine kinase inhibitors (TKIs). In this retrospective study, we sought to evaluate the safety and efficacy of TKIs in this particu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa208491-f648-547a-a2b0-206e99097756
DOI: 10.20944/preprints202312.0595.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Safety and Efficacy of TKIs in Very Elderly Patients (≥75 Years) with Chronic Myeloid LeukemiaDOI 10.20944/preprints202312.0595.v1Read

CML in the Very Elderly: The Impact of Comorbidities and TKI Selection in a Real-life Multicenter StudySemantic proximity Read

Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and managementSemantic proximity Read

Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoringSemantic proximity Read

Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoringSemantic proximity Read

Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and managementSemantic proximity Read

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in OncologySemantic proximity Read

Update on the use of hydroxyurea for the early management of chronic-phase- chronic myeloid leukemia: data from a real-world cohortSemantic proximity Read

A review of the European LeukemiaNet recommendations for the management of CML.Semantic proximity Read

[Key points in second-line therapy for chronic myeloid leukemia].Semantic proximity Read

Best First Line Tyrosine Kinase Inhibitor for Chronic Phase Chronic Myeloid Leukemia in Adults: A Network Meta-AnalysisSemantic proximity Read

Clinical roundtable monograph: Unmet needs in the management of chronic myelogenous leukemia.Semantic proximity Read

Is there a best TKI for chronic phase CML?Semantic proximity Read